Baixar PDF
Voltar à página
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
Outcomes after bone marrow versus peripheral blood haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis
Muhammad Kashif Amin; Moazzam Shahzad; Abat Khan; Valiko Begiashvili; Ushna Khan; Matthew McGuirk; Shaun DeJarnette; Sibgha Gull Chaudhary; Iqra Anwar; Nausheen Ahmed; Al-Ola Abdallah; Sunil H. Abhyankar; Joseph P. McGuirk; Anurag K. Singh; Muhammad Umair Mushtaq;
10.1016/j.htct.2025.106222
Long-term follow-up results of ruxolitinib as salvage therapy for chronic graft-versus-host disease
Neslihan Mandaci Sanli; Esen Karaku¿;
Hematol Transfus Cell Ther. 2025;47:
A dream or reality: Consideration of `bloodless¿ hematopoietic stem cell transplants for Jehovah¿s witness patients
Michael MacNeill; Adrienne Fulford; Deanna Caldwell; Uday Deotare;
Hematol Transfus Cell Ther. 2025;47: